Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer (Q233284): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Created claim: summary (P836): Co-targeting PIM-Kinase in medikamentösen Non-Small Cell Lung Cancer, translated_summary)
(‎Changed label, description and/or aliases in nl: translated_label)
label / nllabel / nl
 
Co-targeting PIM kinase in geneesmiddel resistente niet-kleine cel longkanker

Revision as of 10:15, 27 November 2021

Project Q233284 in Ireland
Language Label Description Also known as
English
Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer
Project Q233284 in Ireland

    Statements

    country
    Ireland
    0 references
    EU contribution
    16,929.64 Euro
    0 references
    budget
    33,859.27 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    1 January 2016
    0 references
    end time
    1 January 2018
    0 references
    beneficiary name (string)
    Trinity College Dublin
    0 references
    summary
    Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer (English)
    0 references
    Co-cibler la PIM kinase dans le cancer du poumon non à petites cellules résistant aux médicaments (French)
    point in time
    25 November 2021
    0 references
    Co-targeting PIM-Kinase in medikamentösen Non-Small Cell Lung Cancer (German)
    point in time
    25 November 2021
    0 references

    Identifiers

    Irish Koesio Identifier
    215
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q233284&oldid=16343068"